- Home
- KPRX vs SOS Comparison
KPRX vs SOS Comparison
Compare KPRX & SOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KPRX | SOS |
|---|---|---|
| Founded | 1998 | 2004 |
| Country | United States | China |
| Employees | 13 | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7M | 9.9M |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | KPRX | SOS |
|---|---|---|
| Price | $2.44 | $1.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 56.4K | 40.2K |
| Earning Date | 05-08-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.76 | $0.90 |
| 52 Week High | $4.18 | $8.92 |
Technical Indicators
Market Signals| Indicator | KPRX | SOS |
|---|---|---|
| Relative Strength Index (RSI) | 53.79 | 47.77 |
| Support Level | $2.25 | $1.06 |
| Resistance Level | $2.51 | $1.56 |
| Average True Range (ATR) | 0.15 | 0.08 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 34.12 | 23.82 |
Price Performance
Historical ComparisonAbout KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
About SOS SOS Limited
SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.